newsfilter
← Latest News
Business Wire·

Reata Pharmaceuticals Announces Participation in the Citi 17th Annual BioPharma Conference

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata," the "Company," or "we"), a clinical-stage biopharmaceutical company, today announced that management will participate in investor meetings at the Citi 17th Annual BioPharma Conference on September 7 ��